Purple Innovation Inc (NAS:PRPL)
$ 0.31 -0.012 (-3.67%) Market Cap: 33.98 Mil Enterprise Value: 219.88 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Q4 2024 Purple Innovation Inc Earnings Call Transcript

Mar 13, 2025 / 08:30PM GMT
Release Date Price: $0.6635 (-5.95%)

Key Points

Positve
  • Purple Innovation Inc (PRPL) achieved adjusted EBITDA profitability for the first time in eight quarters, indicating improved financial health.
  • Gross margin improved significantly to 42.9%, up 970 basis points from the previous year, showcasing effective cost management.
  • The successful launch of the PurpleRenew mattress in 170 Costco locations expanded market presence and complemented online sales.
  • The Rejuvenate 2.0 mattress line and expanded pillow collection were well-received, securing new distribution points and generating excitement.
  • Cost-saving initiatives, including manufacturing consolidation, are projected to yield annual EBITDA savings of $25 million to $30 million, enhancing operational efficiency.
Negative
  • Net revenue for the fourth quarter decreased by 11.6% compared to the previous year, reflecting ongoing challenges in consumer demand.
  • The wholesale segment experienced a 23% decline in net revenue for the fourth quarter, indicating difficulties in this sales channel.
  • E-commerce revenue was down 5.3% for the quarter, highlighting challenges in online sales performance.
  • The company anticipates a potential impact of $2 million to $5 million from recently announced US tariffs, which could affect profitability.
  • The broader macroeconomic landscape remains challenging, with softening consumer demand impacting sales performance.
Operator

Thank you for joining Purple Innovation's fourth-quarter 2024 earnings call. A copy of our earnings press release is available on the Investor Relations section of Purple's website at www.Purple.com.

Before we begin, I'd like to remind you that certain statements made in this presentation are forward-looking statements. These statements reflect Purple Innovation's judgment and analysis as of today and are subject to a variety of risks and uncertainties that could cause actual results to differ materially from current expectations. You should not place undue reliance on these forward-looking statements. For more information, please refer to the Risk Factors outlined in our filings with the SEC.

Additionally, today's presentation will reference non-GAAP financial measures such as adjusted gross margin, EBITDA, adjusted EBITDA, and adjusted earnings per share. A reconciliation of these measures to their most comparable GAAP measures can be found in the earnings release available on our website.

With that, I'll turn the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot